Quality control and structural clarity of GLP-1 therapies
With the surge in GLP-1 receptor agonist drugs for weight-loss and diabetes, manufacturers need faster, more sensitive quality control. Concentrated multibounce ATR-FTIR spectroscopy on small quantities of sample enhances sensitivity for detecting subtle structural changes, enabling rapid, label-free monitoring of peptide purity and aggregation.